Abstract:A nanohybrid of the charge-neutral and poorly water-soluble anticancer drug camptothecin (CPT)/graphene oxide (GO)/Mg-Al hydrotalcite-like compounds (HTlc) was synthesized using a coassembly route. For the coassembly route, CPT molecules were initially loaded on the surface of GO nanosheets; the resulting negatively charged CPT-loaded GO nanosheets and the positively charged HTlc nanosheets were then coassembled together into the layered CPT/GO/HTlc nanohybrid, in which the GO nanosheets and the HTlc nanosheets were alternatively stacked and the CPT molecules were located in its interlayer gallery. The so-obtained nanohybrid was characterized using X-ray diffraction, transmission electron microscope, atomic force microscope, scanning electron microscope-energy dispersive spectrometer, Fourier transform infrared spectrometer, ultraviolet-visible spectrophotometry and thermogravimetric analysis/differential scanning calorimetry technique. The mass ratio of GO to HTlc nanosheets in the nanohybrid was 0.63. The loading amount of CPT on the GO nanosheets was 61.0 mg/g, and that in the nanohybrid was 13.4 mg/g. The d-spacing of the CPT/GO composite and the nanohybrid were 0.84 and 1.35 nm, respectively. The in vitro release of CPT from the nanohybrid was examined in pH 7.4 and 4.0 phosphate buffer solutions at 37 degrees C. The results showed that the drug release process could be described with pseudo-second order kinetic model, and exhibited strong pH dependence, namely, the release rate and the percentage release in pH 4.0 buffer were evidently higher than those in pH 7.4 buffer. The pH dependence of CPT release is due to a possible difference in the release mechanism. The CPT release in pH 7.4 buffer was a diffusion-controlled process and the intraparticle diffusion was the rate-limiting step; in pH 4.0 buffer, the dissolution of HTlc layers and the weakening of pi-pi interaction between CPT and GO also played an important role for CPT release. The maximum percentage releases of CPT from the nanohybrid in pH 7.4 and 4.0 buffers were about 26.8% and 31.1%, respectively, higher than that from CPT/GO composites. The coassembly method is a simple route for building drug/GO/HTlc nanohybrids, and the nanohybrids have potential applications in drug delivery.

Thermo-sensitive graphene oxide-polymer nanoparticle hybrids: Synthesis, characterization, biocompatibility and drug delivery

Polydopamine-functionalized Nanographene Oxide: a Versatile Nanocarrier for Chemotherapy and Photothermal Therapy.

Combined Photothermal and Surface-Enhanced Raman Spectroscopy Effect from Spiky Noble Metal Nanoparticles Wrapped Within Graphene-Polymer Layers: Using Layer-by-layer Modified Reduced Graphene Oxide As Reactive Precursors

Fabrication and Antitumor Mechanism of a Nanoparticle Drug Delivery System: Graphene Oxide/Chitosan Oligosaccharide/γ‐Polyglutamic Acid Composites for Anticancer Drug Delivery

Fabrication of Novel PNIPAM@GO Microspheres Loaded with Dual Drugs Featuring On‐demand Drug Release Capability

Biofunctionalized graphene oxide nanosheet for amplifying antitumor therapy: Multimodal high drug encapsulation, prolonged hyperthermal window, and deep-site burst drug release

Grafting of Graphene Oxide with Stimuli-Responsive Polymers by Using ATRP for Drug Release

A Theranostic Prodrug Delivery System Based on Pt(IV) Conjugated Nano-Graphene Oxide with Synergistic Effect to Enhance the Therapeutic Efficacy of Pt Drug

Facile preparation of poly(N-isopropylacrylamide)/graphene oxide nanocomposites for chemo-photothermal therapy

Hierarchical Nanocomposites Of Graphene Oxide And Pegylated Protoporphyrin As Carriers To Load Doxorubicin Hydrochloride For Trimodal Synergistic Therapy

A Targeted Nano Drug Delivery System of AS1411 Functionalized Graphene Oxide Based Composites

Functionalized graphene oxide nanoparticles for cancer cell-specific delivery of antitumor drug.

Facile Synthesis and Characterization of Multifunctional Cobalt-Based Nanocomposites for Targeted Chemo-Photothermal Synergistic Cancer Therapy

Thermoresponsive graphene oxide – starch micro/nanohydrogel composite as biocompatible drug delivery system

PEGylated Doxorubicin Cloaked Nano-Graphene Oxide for Dual-Responsive Photochemical Therapy.

Improving the Drug Delivery Characteristics of Graphene Oxide Based Polymer Nanocomposites Through the “One-Pot” Synthetic Approach of Single-Electron-transfer Living Radical Polymerization

Hyaluronic acid-decorated graphene oxide nanohybrids as nanocarriers for targeted and pH-responsive anticancer drug delivery.

PEGylated Nano-Graphene Oxide As a Nanocarrier for Delivering Mixed Anticancer Drugs to Improve Anticancer Activity

The Fabrication of Rgo/(pll/pasp)3 @DOX Nanorods with Ph-Switch for Photothermal Therapy and Chemotherapy.

Multi-functionalized Graphene Oxide Based Anticancer Drug-Carrier with Dual-Targeting Function and Ph-Sensitivity

Synthesis and Characterization of Camptothecin/Graphene Oxide/Hydrotalcite-like Compounds Nanohybrids